IR
Superintel
Overview
Markets
Watchlist
More
Valeant Pharmaceuticals
Q2 2016 vs Q3 2016
Comparing institutional holders between quarters
Quarters
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile
1
Filed
0
New
0
Closed
0
Increased
1
Decreased
0
Unchanged
0
No Data
Sort by
Q3 2016 shares — high to low
Q3 2016 shares — low to high
Share change — largest gain
Share change — largest cut
% change — largest gain
% change — largest cut
Q3 2016 value — high to low
Value change — largest gain
Value change — largest cut
Institution — A to Z
Filed — newest first
Advent Capital Management
DECREASED
Shares
14,380,000
from 15,380,000
Change
-1,000,000
(-6%)
Value
$12.4K
(+$40)
Filed 2016-11-22
Institution
Status
Q3 2016 ↓
Q2 2016
Change
% Change
Q2 2016 Value
Q3 2016 Value
Value Change
Filed
Advent Capital Management
DECREASED
14,380,000
15,380,000
-1,000,000
-6%
$12.4K
$12.4K
+$40
2016-11-22
Showing 1 of 1 institutions